Abstract
Checkpoints regulate the normal progression of the cell cycle. Disturbance in the normal function of these checkpoints can induce genomic instability, which is associated with cancer initiation. One such form of instability, aneuploidy, can result from alterations of cell cycle checkpoints, and can induce large imbalances in gene copy number. These imbalances could, in turn, alter the expression of gene products involved in cancer development.
Keywords: Aneuploidy, CELL CYCLE REGULATION, Cell Cycle Kinases, CENTRIOLE
Current Genomics
Title: Cell Cycle Checkpoint Genes and Aneuploidy: A Short Review
Volume: 2 Issue: 2
Author(s): William G. Kearns and Johnson M. Liu
Affiliation:
Keywords: Aneuploidy, CELL CYCLE REGULATION, Cell Cycle Kinases, CENTRIOLE
Abstract: Checkpoints regulate the normal progression of the cell cycle. Disturbance in the normal function of these checkpoints can induce genomic instability, which is associated with cancer initiation. One such form of instability, aneuploidy, can result from alterations of cell cycle checkpoints, and can induce large imbalances in gene copy number. These imbalances could, in turn, alter the expression of gene products involved in cancer development.
Export Options
About this article
Cite this article as:
Kearns G. William and Liu M. Johnson, Cell Cycle Checkpoint Genes and Aneuploidy: A Short Review, Current Genomics 2001; 2(2) . https://dx.doi.org/10.2174/1389202013350931
DOI https://dx.doi.org/10.2174/1389202013350931 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
BRCA1-Associated Triple-Negative Breast Cancer and Potential Treatment for Ruthenium-Based Compounds
Current Cancer Drug Targets The Effect of Claudin-5 Overexpression on the Interactions of Claudin-1 and -2 and Barrier Function in Retinal Cells
Current Molecular Medicine Advanced Development Strategies for Biopharmaceutical Cell Culture Processes
Current Pharmaceutical Biotechnology Silimarin and Cancer
Anti-Cancer Agents in Medicinal Chemistry Nonviral Vectors for Cancer Gene Therapy: Prospects for Integrating Vectors and Combination Therapies
Current Gene Therapy Cyclin-Dependent Kinase Inhibitors as Anticancer Drugs
Current Drug Targets The Synergistic Effects of DNA-Targeted Chemotherapeutics and Histone Deacetylase Inhibitors As Therapeutic Strategies for Cancer Treatment
Current Medicinal Chemistry The Control of Cell Cycle in Mouse Primordial Germ Cells: Old and New Players
Current Pharmaceutical Design The Neuroendocrine Component in Bladder Tumors
Current Medicinal Chemistry Molecular Markers of Glioblastoma and the Potential for Integration with Imaging: the Future for Assigning Prognosis and Best Treatment Strategy
Current Molecular Imaging (Discontinued) Target Driven Preclinical Screening for New Antimitotic Chemotherapy Agents
Current Topics in Medicinal Chemistry Prostate Cancer Horizons in the Development of Novel Anti-Cancer Strategies
Current Medicinal Chemistry - Anti-Cancer Agents Repositioning the Old Fungicide Ciclopirox for New Medical Uses
Current Pharmaceutical Design The Current and Future Therapies for Human Osteosarcoma
Current Cancer Therapy Reviews Feature Classification and Analysis of Lung Cancer Related Genes through Gene Ontology and KEGG Pathways
Current Bioinformatics Novel Therapies Against Aggressive and Recurrent Epithelial Cancers by Molecular Targeting Tumor- and Metastasis-Initiating Cells and Their Progenies
Anti-Cancer Agents in Medicinal Chemistry The Role of Apoptosis in Cancer Development and Treatment: Focusing on the Development and Treatment of Hematologic Malignancies
Current Pharmaceutical Design RUNX2 and Osteosarcoma
Anti-Cancer Agents in Medicinal Chemistry Genetic Predisposition to Parkinson’s Disease and Cancer
Current Cancer Drug Targets HPV and Therapeutic Vaccines: Where are We in 2010?
Current Cancer Therapy Reviews